Clinical Study to Evaluate Efficacy and Safety of ASC and Fibringlue or Fibringlue in Patients With Crohn's Fistula
Clinical trial NCT04612465 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04612465
- Sponsor
- Anterogen Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-09
- Primary completion
- 2025-04-08
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.